You are here

cancer

White House To Announce Big Push For Cancer Blood Tests

White House To Announce Big Push For Cancer Blood Tests

Forbes

Flag link:

Bayer’s Euphoria Around New Cancer Medicine Meets Skepticism

Bayer’s Euphoria Around New Cancer Medicine Meets Skepticism

Bloomberg

anetumab ravtansine

Flag link:

Drug maker fined for shorting supplies of cancer drugs in order to raise prices

Drug maker fined for shorting supplies of cancer drugs in order to raise prices

Stat/Pharmalot

Aspen Pharmacare

Flag link:

Medivir slashes jobs, projects for cancer focus

Medivir slashes jobs, projects for cancer focus

BioPharma Dive

Flag link:

The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing

The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing

Cafepharma/Globe Newswire

Myriad Genetics

Flag link:

Abreos Biosciences announces the formation of a French subsidiary, Abreos France, and a research collaboration with the Institut Paoli-Calmettes for therapeutic drug monitoring of biologics

Abreos Biosciences announces the formation of a French subsidiary, Abreos France, and a research collaboration with the Institut Paoli-Calmettes for therapeutic drug monitoring of biologics

CP Wire

Abreos Biosciences

Flag link:

Bristol-Myers to test Opdivo with Nektar drug for several cancers

Bristol-Myers to test Opdivo with Nektar drug for several cancers

Yahoo/Reuters

Bristol-Myers Squibb

PD-1 inhibitors

Flag link:

3 Biotechs That Could Be M&A Targets

3 Biotechs That Could Be M&A Targets

Motley Fool

Seattle Genetics

Array Biopharma

Clovis Oncology

Flag link:

Epizyme Earns $6 Million Milestone Payment from GlaxoSmithKline for Initiation of Clinical Development with First-in-Class PRMT5 Inhibitor

Epizyme Earns $6 Million Milestone Payment from GlaxoSmithKline for Initiation of Clinical Development with First-in-Class PRMT5 Inhibitor

Yahoo

PRMT5 inhibitors

Flag link:

Spectrum Pharmaceuticals' stock drops after cancer treatment voted down by FDA committee

Spectrum Pharmaceuticals' stock drops after cancer treatment voted down by FDA committee

Marketwatch

Spectrum Pharmaceuticals

Flag link:

3 Hottest Cancer Biotech Acquisition Targets After Medivation

3 Hottest Cancer Biotech Acquisition Targets After Medivation

Forbes

Puma Biotechnology

Jazz Pharmaceuticals

Flag link:

The secretive system for vetting cancer drug use needs an urgent overhaul

The secretive system for vetting cancer drug use needs an urgent overhaul

Stat/Pharmalot

Flag link:

Pfizer's Bold Bid to Conquer Cancer

Pfizer's Bold Bid to Conquer Cancer

Motley Fool

immuno-oncology

Flag link:

CAR-T therapies: the future of cancer care, or an industry pipe dream?

CAR-T therapies: the future of cancer care, or an industry pipe dream?

Medical Marketing and Media

immuno-oncology

Flag link:

Boehringer strikes deal to develop protein degrading cancer drugs

Boehringer strikes deal to develop protein degrading cancer drugs

Fierce Biotech

Boehringer Ingelheim

Flag link:

Insys Therapeutics Inc (INSY): FDA Approves Syndros for Cancer, AIDS Patients

Insys Therapeutics Inc (INSY): FDA Approves Syndros for Cancer, AIDS Patients

Bidness, ETC

INSYS Therapeutics

Flag link:

Top Officials Aim To Reshape The FDA To Prepare For 'Avalanche' Of Cancer Products

Top Officials Aim To Reshape The FDA To Prepare For 'Avalanche' Of Cancer Products

Forbes

Flag link:

$200M deal: Merck & Mass. firm to develop personalized cancer vaccines

$200M deal: Merck & Mass. firm to develop personalized cancer vaccines

Bizjournals.com

personalized medicine

Moderna Therapeutics

Flag link:

Eli Lilly Shows Terrific Innovation

Eli Lilly Shows Terrific Innovation

Seeking Alpha

Flag link:

Epizyme’s Cancer Drug Studies to Continue; Some Tumors Wiped Out

Epizyme’s Cancer Drug Studies to Continue; Some Tumors Wiped Out

Bloomberg

non-Hodgkin's lymphoma

Flag link:

Pages